Renal Osteodystrophy: A Fresh Approach (NCT00859612) | Clinical Trial Compass
CompletedNot Applicable
Renal Osteodystrophy: A Fresh Approach
United States464 participantsStarted 2009-03
Plain-language summary
There are two major goals of this project:
1. Comparison of DXA and QCT for diagnosis of bone loss in CKD-5 patients and determination of the prevalence of low bone turnover in CKD-5 patients with bone loss.
2. Identification of the optimal combination of noninvasive tests for definition of the turnover component of ROD.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 18 years or older;
* Chronic maintenance dialysis of at least 3 months' duration;
* Mental competence;
* Willingness to participate in the study;
* Calcidiol levels within normal range.
Exclusion Criteria:
* Pregnancy;
* Systemic illnesses or organ diseases that may affect bone (except type 1 or type 2 diabetes mellitus);
* Clinical condition that may limit study participation (e.g., unstable angina, respiratory distress, infections).
* Chronic alcoholism and/or drug addiction;
* Participation in a study of an investigational drug during the past 90 days;
* Allergy to tetracycline.
* Planning to move out of the area within 2 years of the study;
* On active transplant list;
* Treatment within last 6 months with drugs that may affect bone metabolism (except for treatment with calcitriol, vitamin D analogs and/or calcimimetics).
* Calcidiol level below the normal range. The current routine clinical practice in our dialysis clinics is to check calcidiol status twice yearly and supplement with vitamin D according to serum calcidiol levels. It is therefore unlikely that a substantial number of patients will be excluded due to this exclusion criterion.
What they're measuring
1
Comparison of DXA and QCT for diagnosis of bone loss in CKD-5 patients and determination of the prevalence of low bone turnover in CKD-5 patients with bone loss.